Bravecto Flea and Tick Treatments for Pets

In December 2019, a class-action lawsuit was filed against Merck Animal Health alleging that the company misleadingly markets Bravecto chewable tablets for dogs and topical solutions for dogs and cats as safe ways to treat and prevent fleas and ticks when, according to the complaint, the products are dangerous and may cause neurological adverse reactions. (Palmieri et al v. Intervet Inc. d/b/a Merck Animal Health, Case No. 19-cv22024, D.N.J.)

For more of’s coverage of pet products, click here.

Print Friendly, PDF & Email


Leave a Reply

Back to Top ↑
  • Search Class-Action Tracker

  • Recent Class Actions

  • The Class-Action Tracker is intended to notify consumers about false advertising class-action lawsuits filed around the country, but does not necessarily reflect’s opinion with respect to the lawsuits or disposition of the cases

  • Sign Up for E-mail Updates